L&C Bio Co Ltd
KOSDAQ:290650
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Japan Real Estate Investment Corp
OTC:JREIF
|
JP |
|
Lemonade Inc
NYSE:LMND
|
US |
|
C
|
Cintas Corp
SWB:CIT
|
US |
|
V
|
Vistal Gdynia SA
WSE:VTL
|
PL |
L&C Bio Co Ltd
Other Items
L&C Bio Co Ltd
Other Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
L
|
L&C Bio Co Ltd
KOSDAQ:290650
|
Other Items
-₩55.6B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-97%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Other Items
-₩528.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Other Items
-₩103.1B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Other Items
₩23.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Other Items
-₩202.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-48%
|
CAGR 10-Years
-26%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Other Items
₩82.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
L&C Bio Co Ltd
Glance View
L&C BIO Co., Ltd. develops soft tissue, allografts, and medical devices. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2018-11-01. The firm mainly manufactures and sells human tissue transplant materials used for tissue repair and filler. The firm also produces and sells human tissue-based medical devices and Cosmeceuticals. Its products are used in vascular surgeries, plastic surgeries, general surgeries and others.
See Also
What is L&C Bio Co Ltd's Other Items?
Other Items
-55.6B
KRW
Based on the financial report for Sep 30, 2025, L&C Bio Co Ltd's Other Items amounts to -55.6B KRW.
What is L&C Bio Co Ltd's Other Items growth rate?
Other Items CAGR 5Y
-97%
The average annual Other Items growth rates for L&C Bio Co Ltd have been -5% over the past three years , -97% over the past five years .
